The best of EcoWatch, right in your inbox. Sign up for our email newsletter!
Monsanto and the Poisonous Cartel of GMOs in India
India is steeped in a synthesized controversy created by Monsanto on the first GMO crop supposedly approved for commercialization. Engaged in litigation on many fronts, Monsanto is trying to subvert India's patent laws: Protection of Plant Variety and Farmers Right Act, Essential Commodities Act and Competition Act. It is behaving as if there is no Parliament, no democracy, no sovereign laws in India to which it is subject. Or it simply doesn't have any regard for them.
Light Brigading / Flickr
In another theatre, Monsanto and Bayer are merging. They were one as MoBay (MonsantoBayer), part of the poison cartel of I.G. Farben. The controlling stakes of both corporations lie with the same private equity firms. The expertise of these firms is in war. I.G. Farben, Adolf Hitler's economic powerhouse and pre-war Germany's highest foreign exchange earner, was also a foreign intelligence operation. Hermann Schmitz was president of I.G. Farben, Schmitz's nephew Max Ilgner was a director of I.G. Farben, while Max's brother Rudolph Ilgner ran the New York arm as vice-president of Chemnyco.
Paul Warburg, brother of Max Warburg (board of directors, Farben Aufsichtsrat), founded the U.S. Federal Reserve System. Max Warburg and Hermann Schmitz played a central role in the Farben empire. Other "guiding hands" of Farben Vorstand included Carl Bosch, Fritz ter Meer, Kurt Oppenheim and George von Schnitzler. Each of them was adjudged a "war criminal" after World War II, except Paul Warburg.
Monsanto and Bayer have a long history. They made explosives and lethally poisonous gases using shared technologies and sold them to both sides in the two world wars. The same war chemicals were bought by the Allied and Axis powers, from the same manufacturers, with money borrowed from the same bank.
MoBay supplied ingredients for Agent Orange in the Vietnam War. Around 20 million gallons of MoBay defoliants and herbicides were sprayed over South Vietnam. Children are still being born with birth defects, adults have chronic illnesses and cancers, due to their exposure to MoBay's chemicals. Monsanto and Bayer's cross-licensed Agent Orange resistance has also been cross-developed for decades. Wars were fought, lives lost, nations carved into holy lands — with artificial boundaries that suit colonization and resource grab — while Bayer and Monsanto sold chemicals as bombs and poisons and their brothers provided the loans to buy those bombs.
More recently, Bayer CropScience AG and Monsanto are believed to have entered into a long-term business relationship. This gives Monsanto and Bayer free access to each other's herbicide and paired herbicide resistance technology. Through cross-licensing agreements, mergers and acquisitions, the biotech industry has become the I.G. Farben of today, with Monsanto in the cockpit.
The global chemical and GMO industry—Bayer, Dow Agro, DuPont Pioneer, Mahyco, Monsanto and Syngenta—have come together to form the Federation of Seed Industry of India (FSII) to try and become bigger bullies in this assault on India's farmers, environment and democratically-framed laws that protect the public and the national interest. This is in addition to Association of Biotechnology-Led Enterprises (ABLE), which tried to challenge India's seed price control order issued under the Essential Commodities Act in the Karnataka high court. The case was dismissed.
The new group is not "seed industry;" they produce no seeds. They try to stretch patents on chemicals to claim ownership on seeds, even in countries where patents on seeds and plants are not allowed. This is the case in India, Argentina, Brazil, Mexico and many other countries.
All Monsanto cases in India are related to Monsanto un-scientifically, illegally and illegitimately claiming patents on seed, in contempt of India's laws, and trying to collect royalties from the Indian seed industry and farmers. The FSII is an "I.G. Farben 100-Year Family Reunion," a coming together of independent and autonomous entities.
The Farben family chemical cartel was responsible for exterminating people in concentration camps. It embodies a century of ecocide and genocide, carried out in the name of scientific experimentation and innovation. Today, the poison cartel is wearing G-Engineering clothes and citing the mantra of "innovation" ad nauseam. Hitler's concentration camps were an "innovation" in killing; and almost a century later, the Farben family is carrying out the same extermination—silently, globally and efficiently.
Monsanto's "innovation" of collecting illegal royalties and pushing Indian farmers to suicide is also an innovation in killing without liability, indirectly. Just because there is a new way to kill doesn't make killing right. "Innovation," like every human activity, has limits—set by ethics, justice, democracy, the rights of people and of nature.
I.G. Farben was tried in Nuremberg. We have national laws to protect people, their right to life and public health, and the environment. India's biosafety and patent laws and the Plant Variety Act are designed to regulate greedy owners of corporations with a history of crimes against nature and humanity.
Industry is getting ready to push its next "gene," the GMO mustard (DMH-11). The GMO mustard, being promoted as a public sector "innovation," is based on barnase/barstar/gene system to create male-sterile plants and a bar gene for glufosinate resistance. In 2002, Pro-Agro's (Bayer) application for approval of commercial planting of GM mustard based on the same system was turned down.
Although banned in India, Bayer finds ways to sell glufosinate illegally to Assam's tea gardens and the apple orchards of Himachal Pradesh. Sales agents show the sale of glufosinate under the "others" category to avoid regulation. These chemicals are finding their way into the bodies of our children without government approval. Essentially, all key patents related to the bar gene are held by Bayer Crop Science, which acquired Aventis Cropscience, which itself was created out of the genetic engineering divisions of Schering, Rhone Poulenc and Hoechst. Then Bayer acquired Plant Genetic Systems and entered into cooperation agreement with Evogene, which has patents on genome mapping.
Before any approval is granted to genetically-engineered mustard, the issue of limits to patentability needs to be resolved on the basis of Indian laws and patents on plants and seeds and methods of agriculture must not be allowed. Deepak Pental, a retired professor and GMO-Operative, will not commercialize GMO mustard seed. His officers at Bayer/Monsanto/MoBay will.
Given our experience with GMO cotton, The Ministry of Environment & Forests is considering the option of putting in place guidelines for socio-economic assessment to judge proposed GMO varieties on the basis of factors such as the economy, health, environment, society and culture.
At the core of socio-economic assessment is the issue of monopolies and cartels, and their impact on small farmers. Even though patents on seeds are not allowed, for more than a decade and a half, Monsanto has extracted illegal royalties from Indian farmers, trapping them in debt and triggering an epidemic of farmers' suicides. Monsanto's war on India's foot soldiers—farmers—is a war being waged by the Farben family, on our Earth family.
EcoWatch Daily Newsletter
Global Banks, Led by JPMorgan Chase, Invested $1.9 Trillion in Fossil Fuels Since Paris Climate Pact
By Sharon Kelly
A report published Wednesday names the banks that have played the biggest recent role in funding fossil fuel projects, finding that since 2016, immediately following the Paris agreement's adoption, 33 global banks have poured $1.9 trillion into financing climate-changing projects worldwide.
By Patti Lynn
2018 was a groundbreaking year in the public conversation about climate change. Last February, The New York Times reported that a record percentage of Americans now believe that climate change is caused by humans, and there was a 20 percentage point rise in "the number of Americans who say they worry 'a great deal' about climate change."
England faces an "existential threat" if it does not change how it manages its water, the head of the country's Environment Agency warned Tuesday.
By Jessica Corbett
A new analysis revealed Tuesday that over the past two decades heat records across the U.S. have been broken twice as often as cold ones—underscoring experts' warnings about the increasingly dangerous consequences of failing to dramatically curb planet-warming emissions.
By Madison Dapcevich
Ask any resident of San Francisco about the waterfront parrots, and they will surely tell you a story of red-faced conures squawking or dive-bombing between building peaks. Ask a team of researchers from the University of Georgia, however, and they will tell you of a mysterious string of neurological poisonings impacting the naturalized flock for decades.
The initial cause of the fire was not yet known, but it has been driven by the strong wind and jumped the North Santiam River, The Salem Statesman Journal reported. As of Tuesday night, it threatened around 35 homes and 30 buildings, and was 20 percent contained.
The unanimous verdict was announced Tuesday in San Francisco in the first federal case to be brought against Monsanto, now owned by Bayer, alleging that repeated use of the company's glyphosate-containing weedkiller caused the plaintiff's cancer. Seventy-year-old Edwin Hardeman of Santa Rosa, California said he used Roundup for almost 30 years on his properties before developing non-Hodgkin's lymphoma.
"Today's verdict reinforces what another jury found last year, and what scientists with the state of California and the World Health Organization have concluded: Glyphosate causes cancer in people," Environmental Working Group President Ken Cook said in a statement. "As similar lawsuits mount, the evidence will grow that Roundup is not safe, and that the company has tried to cover it up."
Judge Vince Chhabria has split Hardeman's trial into two phases. The first, decided Tuesday, focused exclusively on whether or not Roundup use caused the plaintiff's cancer. The second, to begin Wednesday, will assess if Bayer is liable for damages.
"We are disappointed with the jury's initial decision, but we continue to believe firmly that the science confirms glyphosate-based herbicides do not cause cancer," Bayer spokesman Dan Childs said in a statement reported by The Guardian. "We are confident the evidence in phase two will show that Monsanto's conduct has been appropriate and the company should not be liable for Mr. Hardeman's cancer."
Some legal experts said that Chhabria's decision to split the trial was beneficial to Bayer, Reuters reported. The company had complained that the jury in Johnson's case had been distracted by the lawyers' claims that Monsanto had sought to mislead scientists and the public about Roundup's safety.
However, a remark made by Chhabria during the trial and reported by The Guardian was blatantly critical of the company.
"Although the evidence that Roundup causes cancer is quite equivocal, there is strong evidence from which a jury could conclude that Monsanto does not particularly care whether its product is in fact giving people cancer, focusing instead on manipulating public opinion and undermining anyone who raises genuine and legitimate concerns about the issue," he said.
Many regulatory bodies, including the U.S. Environmental Protection Agency, have ruled that glyphosate is safe for humans, but the World Health Organization's International Agency for Research on Cancer found it was "probably carcinogenic to humans" in 2015. A university study earlier this year found that glyphosate use increased cancer risk by as much as 41 percent.
Hardeman's lawyers Jennifer Moore and Aimee Wagstaff said they would now reveal Monsanto's efforts to mislead the public about the safety of its product.
"Now we can focus on the evidence that Monsanto has not taken a responsible, objective approach to the safety of Roundup," they wrote in a statement reported by The Guardian.
Hardeman's case is considered a "bellwether" trial for the more than 760 glyphosate cases Chhabria is hearing. In total, there are around 11,200 such lawsuits pending in the U.S., according to Reuters.
University of Richmond law professor Carl Tobias told Reuters that Tuesday's decision showed that the verdict in Johnson's case was not "an aberration," and could possibly predict how future juries in the thousands of pending cases would respond.